Evidence map›Paper›PMID 28303427›Full record

ArticleAnnals of surgical oncology2017

Impact of Endoscopic Ultrasonography on

J B Hulshoff, V E M Mul, H E M de Boer, W Noordzij, T Korteweg, H M van Dullemen, W B Nagengast, V Oppedijk, J P E N Pierie, John Th M Plukker

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of surgical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Contrast-enhanced endoscopic ultrasound for swollen lymph nodes.Journal of medical ultrasonics (2001) · 2023
    Review
  3. Endoscopic Ultrasound Stagingof Esophageal Cancer.Gastroenterology & hepatology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J B HulshoffDepartment of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
V E M MulDepartment of Radiotherapy, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
H E M de BoerDepartment of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
W NoordzijDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
T KortewegDepartment of Radiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
H M van DullemenDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
W B NagengastDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
V OppedijkRadiotherapeutic Institution Friesland, Leeuwarden, The Netherlands.
J P E N PieriePostgraduate School of Medicine, Groningen, The Netherlands.
John Th M PlukkerDepartment of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. j.t.m.plukker@umcg.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn patients with potentially resectable esophageal cancer (EC), the value of endoscopic ultrasonography (EUS) after fluorine-18 labeled fluorodeoxyglucose positron emission tomography with computed tomography (

methodsDuring the period 2009-2015, 318 EC patients were staged as T1-4aN0-3M0 with hybrid

resultsEUS had an impact in 80 (28.7%) patients; it changed the radiation field in 63 (22.6%), curability in 5 (1.8%), lymphadenectomy in 48 (17.2%), and FNA was additional in 21 (7.5%). In patients treated with nCRT (n = 194), EUS influenced treatment in 53 (27.3%) patients; in 38 (19.6%) the radiation field changed, in 3 (1.5%) the curability, in 35 (18.0%) the lymphadenectomy, and in 17 (8.8%) FNA was additional. EUS influenced both the extent of radiation field and nodal resection in 31 (16.0%) nCRT patients.

conclusionsEUS had an impact on the given treatment in approximately 29%. In most patients, the magnitude of EUS found expression in the extent of radiotherapy target volume delineation to upper/high mediastinal lymph nodes.

Indexed as

Fluorodeoxyglucose F18AdenocarcinomaAgedAntineoplastic Combined Chemotherapy ProtocolsBiopsy, Fine-NeedleCarcinoma, Squamous CellCombined Modality TherapyEndosonographyEsophageal NeoplasmsFemaleFollow-Up StudiesHumansLymph Node ExcisionMaleMiddle AgedPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18

Identifiers

PMID28303427
PMCPMC5486848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.